|
|
||||||||
Departments of Neurology (Drs. Kase and Robinson) and Radiology (Drs. Harp and williams), University of South Alabama, Mobile, AL; the Department of Neurology (Drs. Stein, Hier, and Caplan), Michael Reese Hospital, Chicago, IL; the Department of Neurology (Dr. DeWitt), Massachusetts General Hospital, Boston, MA; and the Neurological Institute (Dr. Mohr), Columbia-Presbyterian Medical Center, New York, NY.
Twenty-four patients had intracerebral hemorrhage while they were being treated with anticoagulants. Hypertension was present in 67% of the cases, head trauma was an uncommon preceding event, and simultaneous bleeding in other organs occurred in only one instance. Neurologic abnormalities progressed for several hours in 58%. Seizures occurred at onset in 12.5%. The location of the hemorrhage was as follows: cerebellum (nine cases), lobar white matter (six), basal ganglia (five), thalamus (two), and hemisphere, unspecified (two). In 61%, the hemorrhages occurred within 6 months of therapy. In 75%, the prothrombin time was beyond 11/2 times the control value. Mortality was 62.5%. Survivors had smaller hematomas than did patients with fatal hemorrhage.
Address correspondence and reprint requests to Dr. Kase, Neurology Department, Boston University School of Medicine, 720 Harrison Avenue, Suite 604, Boston, MA 02118.
Presented in part at the thirty-sixth Annual Meeting of the American Academy of Neurology, Boston, MA. April 1984.
Accepted for publication October 23, 1984.
This article has been cited by other articles:
![]() |
M. I. Aguilar, R. G. Hart, C. S. Kase, W. D. Freeman, B. J. Hoeben, R. C. Garcia, J. E. Ansell, S. A. Mayer, B. Norrving, J. Rosand, et al. Treatment of Warfarin-Associated Intracerebral Hemorrhage: Literature Review and Expert Opinion Mayo Clin. Proc., January 1, 2007; 82(1): 82 - 92. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. Goldstein, S. H. Thomas, V. Frontiero, A. Joseph, C. Engel, R. Snider, E. E. Smith, S. M. Greenberg, and J. Rosand Timing of Fresh Frozen Plasma Administration and Rapid Correction of Coagulopathy in Warfarin-Related Intracerebral Hemorrhage Stroke, January 1, 2006; 37(1): 151 - 155. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Flibotte, N. Hagan, J. O'Donnell, S. M. Greenberg, and J. Rosand Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage Neurology, September 28, 2004; 63(6): 1059 - 1064. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Man-Son-Hing and A. Laupacis Anticoagulant-Related Bleeding in Older Persons With Atrial Fibrillation: Physicians' Fears Often Unfounded Arch Intern Med, July 14, 2003; 163(13): 1580 - 1586. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. E. Smith, J. Rosand, K. A. Knudsen, E. M. Hylek, and S. M. Greenberg Leukoaraiosis is associated with warfarin-related hemorrhage following ischemic stroke Neurology, July 23, 2002; 59(2): 193 - 197. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Man-Son-Hing and A. Laupacis Balancing the Risks of Stroke and Upper Gastrointestinal Tract Bleeding in Older Patients With Atrial Fibrillation Arch Intern Med, March 11, 2002; 162(5): 541 - 550. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Schubert Cerebral Hyperemia, Systemic Hypertension, and Perioperative Intracranial Morbidity: Is There a Smoking Gun? Anesth. Analg., March 1, 2002; 94(3): 485 - 487. [Full Text] [PDF] |
||||
![]() |
L. Sjoblom, H.-G. Hardemark, A. Lindgren, B. Norrving, M. Fahlen, M. Samuelsson, L. Stigendal, D. Stockelberg, A. Taghavi, L. Wallrup, et al. Management and Prognostic Features of Intracerebral Hemorrhage During Anticoagulant Therapy: A Swedish Multicenter Study Stroke, November 1, 2001; 32(11): 2567 - 2574. [Abstract] [Full Text] [PDF] |
||||
![]() |
O G Nilsson, A Lindgren, N Stahl, L Brandt, and H Saveland Incidence of intracerebral and subarachnoid haemorrhage in southern Sweden J. Neurol. Neurosurg. Psychiatry, November 1, 2000; 69(5): 601 - 607. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Berwaerts, R. S. Dijkhuizen, O. J. Robb, and J. Webster Prediction of Functional Outcome and In-Hospital Mortality After Admission With Oral Anticoagulant-Related Intracerebral Hemorrhage Stroke, November 1, 2000; 31(11): 2558 - 2562. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Crawley, D. Bevan, and D. Wren Management of intracranial bleeding associated with anticoagulation: balancing the risk of further bleeding against thromboembolism from prosthetic heart valves J. Neurol. Neurosurg. Psychiatry, September 1, 2000; 69(3): 396 - 398. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Berwaerts and J. Webster Analysis of risk factors involved in oral-anticoagulant-related intracranial haemorrhages QJM, August 1, 2000; 93(8): 513 - 521. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Man-Son-Hing, G. Nichol, A. Lau, and A. Laupacis Choosing Antithrombotic Therapy for Elderly Patients With Atrial Fibrillation Who Are at Risk for Falls Arch Intern Med, April 12, 1999; 159(7): 677 - 685. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Brass, H. M. Krumholz, J. M. Scinto, and M. Radford Warfarin Use Among Patients With Atrial Fibrillation Stroke, December 1, 1997; 28(12): 2382 - 2389. [Abstract] [Full Text] |
||||
![]() |
F.E. Munschauer, R.L. Priore, M. Hens, and A. Castilone Thromboembolism Prophylaxis in Chronic Atrial Fibrillation: Practice Patterns in Community and Tertiary-Care Hospitals Stroke, January 1, 1997; 28(1): 72 - 76. [Abstract] [Full Text] |
||||
![]() |
The Stroke Prevention in Atrial Fibrillation Inves Bleeding During Antithrombotic Therapy in Patients With Atrial Fibrillation Arch Intern Med, February 26, 1996; 156(4): 409 - 416. [Abstract] [PDF] |
||||
![]() |
R. G. Hart, B. S. Boop, and D. C. Anderson Oral Anticoagulants and Intracranial Hemorrhage : Facts and Hypotheses Stroke, August 1, 1995; 26(8): 1471 - 1477. [Abstract] [Full Text] |
||||
![]() |
D.B. Cines and M. Laposata Case 15-1995- A 70-year-old woman with atrial fibrillation and the rapid onset of hemorrhagic manifestations N. Engl. J. Med., May 18, 1995; 332(20): 1363 - 1370. [Full Text] [PDF] |
||||
![]() |
G. W. Albers Atrial Fibrillation and Stroke: Three New Studies, Three Remaining Questions Arch Intern Med, July 11, 1994; 154(13): 1443 - 1448. [Abstract] [PDF] |
||||
![]() |
J. C Grotta Prevention and management of stroke Vascular Medicine, March 1, 1991; 2(1): 3 - 17. [PDF] |
||||
![]() |
C. S. Kase, A. M. O'Neal, M. Fisher, G. N. Girgis, and J. I. Ordia Intracranial Hemorrhage after Use of Tissue Plasminogen Activator for Coronary Thrombolysis Ann Intern Med, January 1, 1990; 112(1): 17 - 21. [Abstract] [PDF] |
||||
![]() |
M. J. Alberts, E. W. Massey, and D. Dawson A Multicenter Study of Anticoagulation Parameters When Using Heparin and Warfarin Arch Neurol, December 1, 1987; 44(12): 1229 - 1231. [Abstract] [PDF] |
||||
![]() |
P. D. Lyden, J. A. Zivin, M. Soll, M. Sitzer, J. F. Rothrock, and J. Alksne Intracerebral Hemorrhage After Experimental Embolic Infarction: Anticoagulation Arch Neurol, August 1, 1987; 44(8): 848 - 850. [Abstract] [PDF] |
||||
![]() |
M. A. Sloan Thrombolysis and Stroke: Past and Future Arch Neurol, July 1, 1987; 44(7): 748 - 768. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |